Skip to main content

Closed

MIRA: MIRA Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-104.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio82.16×

MIRA Pharmaceuticals, Inc.

MIRANASDAQ Capital Market·USD·Closed

MIRA Pharmaceuticals, Inc.

MIRANASDAQ·USD·Closed

$0.79

−2.98%

$0.79

−$0.02 (2.98%)

52W Range

1thpctl

Volume

0.88×avg

Mkt Cap

33.28MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.88×avg

Market Cap

33.28MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings